Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 2
2022 7
2023 6
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Serum/Plasma Proteome in Non-Malignant Liver Disease.
Fu L, Guldiken N, Remih K, Karl AS, Preisinger C, Strnad P. Fu L, et al. Int J Mol Sci. 2024 Feb 7;25(4):2008. doi: 10.3390/ijms25042008. Int J Mol Sci. 2024. PMID: 38396688 Free PMC article. Review.
Long-term hypercaloric diet exacerbates metabolic liver disease in PNPLA3 I148M animals.
Su H, Haque M, Becker S, Edlund K, Duda J, Wang Q, Reißing J, Marschall HU, Candels LS, Mohamed M, Sjöland W, Liao L, Drexler SA, Strowig T, Rahnenführer J, Hengstler JG, Hatting M, Trautwein C. Su H, et al. Liver Int. 2023 Aug;43(8):1699-1713. doi: 10.1111/liv.15587. Epub 2023 Apr 18. Liver Int. 2023. PMID: 37073116
Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis.
Gurbuz B, Guldiken N, Reuken P, Fu L, Remih K, Preisinger C, Brůha R, Leníček M, Petrtýl J, Reissing J, Aly M, Fromme M, Zhou B, Karkossa I, Schubert K, von Bergen M, Stallmach A, Bruns T, Strnad P. Gurbuz B, et al. Hepatol Int. 2023 Jun;17(3):698-708. doi: 10.1007/s12072-022-10473-x. Epub 2023 Jan 18. Hepatol Int. 2023. PMID: 36652164 Free PMC article.
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming.
Colyn L, Alvarez-Sola G, Latasa MU, Uriarte I, Herranz JM, Arechederra M, Vlachogiannis G, Rae C, Pineda-Lucena A, Casadei-Gardini A, Pedica F, Aldrighetti L, López-López A, López-Gonzálvez A, Barbas C, Ciordia S, Van Liempd SM, Falcón-Pérez JM, Urman J, Sangro B, Vicent S, Iraburu MJ, Prosper F, Nelson LJ, Banales JM, Martinez-Chantar ML, Marin JJG, Braconi C, Trautwein C, Corrales FJ, Cubero FJ, Berasain C, Fernandez-Barrena MG, Avila MA. Colyn L, et al. J Exp Clin Cancer Res. 2022 May 26;41(1):183. doi: 10.1186/s13046-022-02386-2. J Exp Clin Cancer Res. 2022. PMID: 35619118 Free PMC article.
22 results